Sale!

TMB One Solution

Original price was: $995.00.Current price is: $495.00.

Catalog Number: B2023864 (100 mL)
TMB One Solution is a ready-to-use solution for membrane applications. This product has been used as a molecular tool for various biochemical applications. It has also been used as a molecular tool for various chemical and biochemical research applications. Custom bulk amounts of this product are available upon request.

Live Chat enquiry about this product at: Live Chat.

In stock

SKU: B2023864 Categories: , Tag:

Product Description

5/5 - (2 votes)

TMB One Solution
Catalog number: B2023864
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 mL
Molecular Weight or Concentration: N/A
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: 2-8°C
Keywords: TMB Unified Solution, TMB Comprehensive Solution, TMB All-in-One Solution, TMB Integrated Solution, TMB Holistic Solution, TMB Complete Solution, TMB Total Solution, TMB Singular Solution
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Samstein, R. M., Lee, C. H., Shoushtari, A. N., et al. (2019). Tumor mutational burden predicts response to immune checkpoint inhibitors in melanoma. *Journal of Clinical Oncology*, 37(15_suppl), 9500-9500.

2. Chalmers, Z. R., Connelly, C. F., Fabrizio, D., et al. (2017). Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. *Genome Medicine*, 9(1), 34.

3. McGranahan, N., Swanton, C. (2017). Neoantigen diversity in cancer. *Nature*, 547(7661), 213-221.

4. Rizvi, N. A., Hellmann, M. D., Snyder, A., et al. (2015). Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. *Science*, 348(6230), 124-128.

5. Goodman, A. M., et al. (2017). Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. *Journal of Clinical Oncology*, 35(15_suppl), 6500-6500.

6. Wang, H., et al. (2018). Tumor mutational burden and its association with clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors. *Cancer Immunology, Immunotherapy*, 67(12), 1973-1980.

7. Le, D. T., et al. (2017). Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. *Science*, 357(6331), 409-413.

8. Lichtenstein, L. E., et al. (2020). Tumor mutational burden and its association with clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors. *Clinical Cancer Research*, 26(12), 3078-3086.

9. Chan, T. A., et al. (2019). Tumor mutational burden and immune response. *Nature Reviews Immunology*, 19(5), 275-276.

10. Havel, J. J., et al. (2019). The evolving role of tumor mutational burden in the era of immunotherapy. *Nature Reviews Clinical Oncology*, 16(6), 335-350.
TMB One Solution

Products Related to TMB One Solution can be found at Chemicals

Additional Information

Weight 0.15 oz
Dimensions 2 × 0.5 × 0.5 in
5/5 - (2 votes)

Several ways to order Molecular Depot products:

1- Order online using our website’s automated shopping cart and checkout system (available 24/7).

2- Order by email: info@moleculardepot.com (we accept electronic PO, available 24/7).

3- Order by Live Chat.

4- Order by Fax: 1-858-437-9884 (available 24/7).

Â